| Almirall AG - Wynzora 50 μg/g + 0.5 mg/g, Crème | | 68917 | | 01 | | Wynzora 50 μg/g + 0.5 mg/g | | Crème | | D05AX52 | | Calcipotriol, combinations | | 10.10.2023 | | |
| | Composition | | calcipotriolum 0.05 mg, betamethasonum 0.5 mg ut betamethasoni dipropionas, isopropylis myristas, paraffinum liquidum, triglycerida media, alcohol isopropylicus, macrogoli 4 aether laurilicus, poloxamerum 407, macrogolglyceroli hydroxystearas 3.37 mg, carbomerum interpolymerum A, E 320 1 mg, trolaminum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, E 307, aqua purificata q.s. ad unguentum pro 1 g. | | Packungsbestandteile | | Crème | | | | | | | | Principe actif | Concentr. |
|---|
| Betamethasone | 0.5 mg | | Calcipotriol | 0.05 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Betamethasone | 0.5 mg | | Calcipotriol | 0.05 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Aether Laurilicus | | | Alcohol Isopropylicus | | | Aqua Purificata | | | Carbomerum Interpolymerum A | | | Disodium Phosphate Heptahydrate | | | E 307 | | | E 320 | 1 mg | | Isopropyl Myristate | | | Macrogolglyceroli Hydroxystearas | 3.37 mg | | Macrogoli | 4 | | Sodium Dihydrogenophosphate Monohydrate | | | Paraffine Liquide | | | Poloxamer | 407 | | Triglycerida Media | | | Trolaminum | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 60 g | 39.33 | 59.00 | B | LS | Non | | 002 | 120 g | 69.22 | 90.25 | B | LS | Non |
|
|
